Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Hyperphenylalaninaemia due to impaired dihydrobiopterin biosynthesis: Leukocyte function and effect of tetrahydrobiopterin therapy

  • 24 Accesses

  • 7 Citations

Abstract

We have described the clinical and biochemical status of two patients with tetrahydrobiopterin (BH4) deficiency due to impaired dihydrobiopterin biosynthesis. BH4 administration appeared to improve the mental and psychological status more than did neurotransmitter replacement therapy alone. This enhancement of activities of daily life was seen with a dose of BH4 as low as 1.25 mg kg−1 day−1. Granulocyte adherence capacity was below normal and recovered after BH4 therapy in both patients. B-cell differentiation capacity was altered either before or after therapy.

This is a preview of subscription content, log in to check access.

References

  1. Bartholomé, K. A new molecular defect in phenylketonuria.Lancet 2 (1974) 1580

  2. Bartholomé, K. and Byrd, D. J.l-Dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine-hydroxylase activity.Lancet 1 (1975) 1042–1043

  3. Danks, D. M., Bartholomé, K., Clayton, B. E., Curtius, H., Gröbe, H. and Rey, F. Malignant hyperphenylalaninemia — Current status (June, 1977).J. Inher. Metab. Dis. 1 (1978) 49–53

  4. Fukuda, K., Nishi, Y. and Usui, T. Free amino acid concentrations in plasma, erythrocytes, granulocytes, and lymphocytes in umbilical cord blood, children, and adults.J. Pediatr. Gastroenterol. Nutr. 3 (1984) 432–439

  5. Hase, Y., Shintaku, H., Turuhara, T. and Oura, T. A case of tetrahydrobiopterin deficiency due to a defective synthesis of dihydrobiopterin.J. Inher. Metab. Dis. 5 (1982) 81–82

  6. Horino, N. Impaired PWM-induced polyclonal B-cell activation in patients with malignancies treated with various intermittent combination chemotherapies including doxorubicin.Cancer 50 (1982) 659–667

  7. Hyodo, S., Kishi, T., Kittaka, E., Suzawa, T., Tanabe, A., Tanaka, Y., Sakano, T. and Usui, T. Inhibition of phytohaemagglutinin-induced autorosette formation of human peripheral blood lymphocytes by RNA or protein synthesis inhibitor.Clin. Exp. Immunol. 53 (1983) 140–144

  8. Kobayashi, Y. and Usui, T. Opsonic activity of cord serum — an evaluation based on determination of oxygen consumption by leukocytes.Pediatr. Res. 16 (1982) 243–246

  9. Kohashi, M., Tomita, K. and Iwai, K. Analysis of unconjugated pterins in food resources and human urine.Agric. Biol. Chem. 44 (1980) 2089–2094

  10. MacGregor, R. R., Spagnuolo, P. J. and Lentnek A. L. Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system.N. Engl. J. Med. 291 (1974) 642–645

  11. Milstien, S., Holtzman, N. A., O'Flynn, M. E., Thomas, G. H., Butler, I. J. and Kayfman, S. Hyperphenylalaninemia due to dihydropteridine reductase deficiency.J. Pediatr. 89 (1976) 763–766

  12. Nelson, R. D., Quie, P. G. and Simmons, R. L. Chemotaxis under agarose: A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes.J. Immunol. 115 (1975) 1650–1656

  13. Niederwieser, A., Curtius, H. C., Wang, M. and Leupold, D. Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man.Eur. J. Pediatr. 138 (1982) 110–112

  14. Quie, P. G., White, J. G., Holmes, B. and Good, R. A.In vitro bactericidal capacity of human polymorphonuclear leukocytes: Diminished activity in chronic granulomatous disease of children.J. Clin. Invest. 46 (1967) 668–679

  15. Smith, I. Atypical phenylketonuria accompanied by a severe progressive neurological illness unresponsive to dietary treatment (Abstract).J. Inher. Metab. Dis. 1 (1974) 49–53

  16. Tanabe, A., Kobayashi, Y. and Usui, T. Enhancement of human neutrophil oxygen consumption by chemotactic factors.Experientia 39 (1983) 604–606

  17. Tanaka, T., Aihara, K., Iwai, K., Kohashi, M., Tomita, K., Narisawa, K., Arai, N., Yoshida, H. and Usui, T. Hyperphenylalaninemia due to impaired dihydrobiopterin biosynthesis.Eur. J. Pediatr. 136 (1981) 275–280

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fukuda, K., Tanaka, T., Hyodo, S. et al. Hyperphenylalaninaemia due to impaired dihydrobiopterin biosynthesis: Leukocyte function and effect of tetrahydrobiopterin therapy. J Inherit Metab Dis 8, 49–52 (1985). https://doi.org/10.1007/BF01801661

Download citation

Keywords

  • Public Health
  • Internal Medicine
  • Replacement Therapy
  • Metabolic Disease
  • Differentiation Capacity